Overview

Neomycin and Metronidazole Hydrochloride With or Without Polyethylene Glycol in Reducing Infection in Patients Undergoing Elective Colorectal Surgery

Status:
Unknown status
Trial end date:
2021-10-01
Target enrollment:
0
Participant gender:
All
Summary
This randomized clinical trial studies how well neomycin and metronidazole hydrochloride with or without polyethylene glycol work in reducing infection in patients undergoing elective colorectal surgery. Polyethylene glycol, may draw water from the body into the colon, flushing out the contents of the colon. Antibiotics, like neomycin and metronidazole hydrochloride, may stop bacteria from growing. It is not yet known whether it's better to give preoperative neomycin and metronidazole hydrochloride with or without polyethylene glycol in reducing surgical site infection after colorectal surgery.
Phase:
Early Phase 1
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Sidney Kimmel Cancer Center at Thomas Jefferson University
Thomas Jefferson University
Treatments:
Anti-Bacterial Agents
Antibiotics, Antitubercular
Ethanol
Metronidazole
Neomycin
Criteria
Inclusion Criteria:

- Patients undergoing ileocolic resections, partial and total colectomies, and rectal
resections for neoplasm, inflammatory bowel disease, or diverticulitis

- Subjects with the mental capacity to give informed consent

Exclusion Criteria:

- Patients undergoing emergent colorectal resections

- Patients who are decisionally-impaired and lack the mental capacity to give informed
consent